Formulating RGC Budgets for Clinical Medicine & Trials

1. Financial Alignment & Eligibility Standards

Securing research funding from Research Grants Council requires meticulous adherence to both financial eligibility standards and administrative regulations. For projects in the domain of Clinical Medicine & Trials, budgets must be constructed using realistic cost projections that are directly tied to the scientific methodology. Under-budgeting may jeopardise project execution, while over-budgeting or including ineligible costs often leads to immediate rejection during administrative screening.

For wet-lab research in Clinical Medicine & Trials, budget formulations must prioritize chemical reagents, specialized assay consumables, and pay-per-use core facility fees. Investigators should avoid pooling general office supplies with specialized scientific consumables to prevent auditing flags during reviews of RGC proposals.

Proposal teams must submit all budget items in the host institution's local currency, mapping them to the specific electronic submission environment (RGC Electronic System). Every cost item must be justifiable as necessary, reasonable, and allocable to the project.

2. Direct vs. Indirect Cost Categorisation

A primary point of auditing compliance is the strict division between Direct Costs (expenses directly attributable to the execution of the research project) and Indirect Costs (institutional overheads, facility maintenance, and central administrative support).

Indirect overheads are strictly regulated under the **RGC** cap: **Oncost allowances**. Institutional finance offices must review calculations to ensure correct base rate applications to the **Clinical Medicine & Trials** direct cost matrix.

For RGC proposals, the indirect cost rate is structured as: Oncost allowances. This rate must be applied correctly to the modified total direct cost base according to your institution's negotiated rate agreement or the flat rate set by the funder.

3. Step-by-Step Budget Justification Protocol

The budget justification (or budget narrative) is a critical component of the application reviewed by both financial auditors and peer reviewers. To draft a compliant narrative:

• Provide granular detail: Do not use lump sums. Break down personnel costs by calendar months or percentage of effort.
• Demonstrate direct linkage: For every cost, explain how it supports a specific task or objective in the research plan for Clinical Medicine & Trials.
• Cite institutional policies: Reference verified institutional rates for fringe benefits, travel mileage, and indirect cost bases to validate your numbers.
• Verify supplier quotes: For major equipment purchases or specialized laboratory assays, upload or reference formal vendor quotes.

Pre-Award Framework, Cost Sharing & Post-Award Governance

Pre-award research offices supporting grant development and pre-award grant management for RGC awards in Clinical Medicine & Trials must evaluate all eligible direct lines early in the application process. Unlike discretionary block grants given directly to departments, these funds are administered as categorical grants restricted to specified scientific deliverables under RGC rules. Both the PI and the designated co-principal investigator must plan the grant proposal timeline to accommodate complex administrative checks, including verifying and declaring any institutional cost sharing on grants. Post-award compliance enforces systematic post-award grant management, which includes drafting a formal subaward agreement research with participating research groups. This compliance framework enforces strict effort certification research timesheets and close financial coordination to support cohesive team science research across all participating sites.

4. Frequently Asked Questions